tirzepatide blindness from In pts wiht HFpEF and obesity, tirzepatide (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https://t.co/8ZHm4gySiL Zepbound Blindness Lawsuit [2026 Update]
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
![tirzepatide blindness from In pts wiht HFpEF and obesity, tirzepatide (Mounjaro) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https://t.co/8ZHm4gySiL Zepbound Blindness Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/09/how-many-people-get-naion-from-zepbound.webp)
![tirzepatide blindness from In pts wiht HFpEF and obesity, tirzepatide (Mounjaro) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https://t.co/8ZHm4gySiL Zepbound Blindness Lawsuit [2026 Update]](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-024-02319-7/MediaObjects/12933_2024_2319_Figa_HTML.png)
![tirzepatide blindness from In pts wiht HFpEF and obesity, tirzepatide (Mounjaro) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https://t.co/8ZHm4gySiL Zepbound Blindness Lawsuit [2026 Update]](https://assets.poison.org/1024x768/09f61dcd7c/tirzepatide-injection-with-measuring-tape.jpg)
























